Cubist Systematic Strategies’s Blueprint Medicines BPMC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-46,602
| Closed | -$5.97M | – | 3030 |
|
|
2025
Q2 | $5.97M | Buy |
+46,602
| New | +$4.84M | 0.03% | 908 |
|
|
2024
Q3 | – | Sell |
-4,901
| Closed | -$487K | – | 3009 |
|
|
2024
Q2 | $528K | Buy |
+4,901
| New | +$491K | ﹤0.01% | 2101 |
|
|
2022
Q4 | – | Sell |
-28,037
| Closed | -$1.85M | – | 4259 |
|
|
2022
Q3 | $1.85M | Sell |
28,037
-19,576
| -41% | -$1.26M | 0.01% | 2084 |
|
|
2022
Q2 | $2.4M | Buy |
47,613
+16,169
| +51% | +$947K | 0.01% | 1672 |
|
|
2022
Q1 | $2.01M | Buy |
31,444
+22,745
| +261% | +$1.63M | 0.02% | 1479 |
|
|
2021
Q4 | $932K | Buy |
8,699
+8,076
| +1,296% | +$845K | 0.01% | 1969 |
|
|
2021
Q3 | $64K | Sell |
623
-36,404
| -98% | -$3.39M | ﹤0.01% | 2813 |
|
|
2021
Q2 | $3.26M | Buy |
37,027
+23,251
| +169% | +$2.13M | 0.04% | 785 |
|
|
2021
Q1 | $1.34M | Sell |
13,776
-21,402
| -61% | -$2.14M | 0.02% | 1329 |
|
|
2020
Q4 | $3.94M | Buy |
35,178
+31,721
| +918% | +$3.34M | 0.05% | 552 |
|
|
2020
Q3 | $320K | Sell |
3,457
-199
| -5% | -$15.3K | ﹤0.01% | 1963 |
|
|
2020
Q2 | $285K | Sell |
3,656
-12,494
| -77% | -$845K | ﹤0.01% | 1870 |
|
|
2020
Q1 | $944K | Buy |
16,150
+3,602
| +29% | +$232K | 0.03% | 870 |
|
|
2019
Q4 | $1M | Buy |
12,548
+2,540
| +25% | +$190K | 0.02% | 1156 |
|
|
2019
Q3 | $735K | Buy |
+10,008
| New | +$865K | 0.01% | 1125 |
|
|
2019
Q2 | – | Sell |
-7,212
| Closed | -$577K | – | 2453 |
|
|
2019
Q1 | $577K | Buy |
+7,212
| New | +$533K | 0.02% | 1095 |
|
|
2018
Q4 | – | Sell |
-3,520
| Closed | -$275K | – | 2060 |
|
|
2018
Q3 | $275K | Buy |
+3,520
| New | +$245K | 0.02% | 1217 |
|
|
2018
Q2 | – | Sell |
-200
| Closed | -$18K | – | 1793 |
|
|
2018
Q1 | $18K | Sell |
200
-972
| -83% | -$83.8K | ﹤0.01% | 1752 |
|
|
2017
Q4 | $88K | Buy |
1,172
+1,126
| +2,448% | +$79.2K | ﹤0.01% | 1700 |
|
|
2017
Q3 | $3K | Sell |
46
-791
| -95% | -$42.3K | ﹤0.01% | 1802 |
|
|
2017
Q2 | $42K | Sell |
837
-1,894
| -69% | -$80.4K | ﹤0.01% | 1561 |
|
|
2017
Q1 | $109K | Buy |
+2,731
| New | +$97.8K | 0.01% | 1375 |
|
Other funds holding BPMC
IA
HNB
Cubist Systematic Strategies's BPMC Position: Q3 2025 in Review
Cubist Systematic Strategies sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 46,602 shares — an estimated $5.97M sold.
Cubist Systematic Strategies first reported a position in BPMC in Q1 2017 and held it in 22 quarters. The position peaked at $5.97M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.
- Cubist Systematic Strategies reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
- Cubist Systematic Strategies sold 46,602 Blueprint Medicines shares in Q3 2025, an estimated $5.97M.
- Cubist Systematic Strategies first reported a position in Blueprint Medicines in Q1 2017 and held it in 22 quarters.
- Cubist Systematic Strategies's Blueprint Medicines position peaked at $5.97M in Q2 2025.
- 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.
Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.